Biomimetic Subcellular Chemomechanical Nano‐Regulator for Allergic Rhinitis Treatment

Allergic rhinitis (AR) is a highly prevalent and debilitating chronic inflammatory disease; however, its complex pathophysiological mechanisms remain incompletely explored, resulting in a significant lack of effective therapeutic strategies in clinical practice. Here, we found that the submucosal extracellular matrix undergoes profound pathological stiffening during AR development and is associated with severe epithelial mechanometabolic dysfunction and physical barrier collapse. Based on this pathomechanical observation, we developed a spatiotemporally programmable subcellular chemomechanical regulator (SCM) to reconstruct the damaged mucosal barrier. Capitalizing on its precise targeting and cascade-responsive capabilities, SCM provides immediate anti-inflammatory activity to stabilize stressed epithelial cells. Beyond this acute intervention, the regulator scavenges intracellular free radicals, attenuates pathological mitochondria-associated membrane (MAM) over-coupling, and restores mitochondrial metabolic homeostasis. In parallel, the Mn-containing nanocore and pirfenidone jointly attenuate fibroblast activation and abnormal extracellular-matrix stiffening. Formulation-resolved cellular and animal studies distinguished a predominant TA-associated contribution to early inflammatory and epithelial-barrier responses from a predominant PFD-associated contribution to later matrix remodeling. Full SCM combined these stage-associated response domains while rebuilding epithelial-barrier integrity and shifting systemic immune readouts toward tolerance. These findings provide a preclinical mechanobiology-guided framework for treating AR and other mechanically driven inflammatory diseases.

Authors

Institutions

Publication Details

Journal
Advanced Materials
Published
2026-11-18
DOI
https://doi.org/10.1002/adma.75732
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biomimetic Subcellular Chemomechanical Nano‐Regulator for Allergic Rhinitis Treatment

Wenwen Qi, Jian Liu, Fangyuan Zhu, Chengcheng Liu et al.
3 links
Advanced Materials
Allergic Rhinitis and Sensitization
article

Biomimetic Subcellular Chemomechanical Nano‐Regulator for Allergic Rhinitis Treatment

Wenwen Qi, Jian Liu, Fangyuan Zhu, Chengcheng Liu, Ming Xia, Hongjie Du, Xu Guo, Shengjie Ge, Zhaoze Yang, Yuanjin Zhao, Xiaochen Gao, Lei Shi
article en

Abstract

Allergic rhinitis (AR) is a highly prevalent and debilitating chronic inflammatory disease; however, its complex pathophysiological mechanisms remain incompletely explored, resulting in a significant lack of effective therapeutic strategies in clinical practice. Here, we found that the submucosal extracellular matrix undergoes profound pathological stiffening during AR development and is associated with severe epithelial mechanometabolic dysfunction and physical barrier collapse. Based on this pathomechanical observation, we developed a spatiotemporally programmable subcellular chemomechanical regulator (SCM) to reconstruct the damaged mucosal barrier. Capitalizing on its precise targeting and cascade-responsive capabilities, SCM provides immediate anti-inflammatory activity to stabilize stressed epithelial cells. Beyond this acute intervention, the regulator scavenges intracellular free radicals, attenuates pathological mitochondria-associated membrane (MAM) over-coupling, and restores mitochondrial metabolic homeostasis. In parallel, the Mn-containing nanocore and pirfenidone jointly attenuate fibroblast activation and abnormal extracellular-matrix stiffening. Formulation-resolved cellular and animal studies distinguished a predominant TA-associated contribution to early inflammatory and epithelial-barrier responses from a predominant PFD-associated contribution to later matrix remodeling. Full SCM combined these stage-associated response domains while rebuilding epithelial-barrier integrity and shifting systemic immune readouts toward tolerance. These findings provide a preclinical mechanobiology-guided framework for treating AR and other mechanically driven inflammatory diseases.

Advanced Materials
Shandong University (CN), Nanjing Drum Tower Hospital (CN), Shandong Provincial Hospital (CN), Shandong First Medical University (CN), Southeast University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Shandong Province
Good health and well-being
Allergic Rhinitis and Sensitization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon